Qiubai Li

4.6k total citations · 1 hit paper
99 papers, 3.3k citations indexed

About

Qiubai Li is a scholar working on Molecular Biology, Hematology and Cancer Research. According to data from OpenAlex, Qiubai Li has authored 99 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 27 papers in Hematology and 22 papers in Cancer Research. Recurrent topics in Qiubai Li's work include Extracellular vesicles in disease (22 papers), Acute Myeloid Leukemia Research (14 papers) and MicroRNA in disease regulation (13 papers). Qiubai Li is often cited by papers focused on Extracellular vesicles in disease (22 papers), Acute Myeloid Leukemia Research (14 papers) and MicroRNA in disease regulation (13 papers). Qiubai Li collaborates with scholars based in China, United States and United Kingdom. Qiubai Li's co-authors include Zhichao Chen, Hongxiang Wang, An‐Yuan Guo, Qian Lei, Teng Liu, Ping Zou, William K. Holloman, Haijuan Yang, Nikola P. Pavletich and Jie Fan and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Qiubai Li

94 papers receiving 3.3k citations

Hit Papers

Extracellular Vesicles: A Review of Their Therapeutic Pot... 2025 2026 2025 5 10 15
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Extracellular Vesicles: A Review of Their Therapeutic Potentials, Sources, Biodistribution, and Administration Routes
    2025 19 citations Hongxiang Wang, Qiubai Li et al. profile →

Peers

Qiubai Li
Xin Du China
Bo Zheng China
Myungshin Kim South Korea
José Vassallo Brazil
David M. Smadja France
Aline Bözec Germany
Kiarash Khosrotehrani Australia
Léo H. Bühler Switzerland
Andrea Onetti Muda Italy
Bing Liu China
Xin Du China
Qiubai Li
Citations per year, relative to Qiubai Li Qiubai Li (= 1×) peers Xin Du

Countries citing papers authored by Qiubai Li

Since Specialization
Citations

This map shows the geographic impact of Qiubai Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiubai Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiubai Li more than expected).

Fields of papers citing papers by Qiubai Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qiubai Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiubai Li. The network helps show where Qiubai Li may publish in the future.

Co-authorship network of co-authors of Qiubai Li

This figure shows the co-authorship network connecting the top 25 collaborators of Qiubai Li. A scholar is included among the top collaborators of Qiubai Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qiubai Li. Qiubai Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Haikun, Shen Wang, Qiubai Li, et al.. (2025). Munc13-4 mediates tumor immune evasion by regulating the sorting and secretion of PD-L1 via exosomes. Nature Communications. 16(1). 9080–9080.
2.
Zhao, Xudong, Shunji Li, Yulin Cao, et al.. (2025). Fully Integrated Centrifugal Microfluidics for Rapid Exosome Isolation, Glycan Analysis, and Point-of-Care Diagnosis. ACS Nano. 19(9). 8948–8965. 13 indexed citations
3.
4.
Jang, Albert, Jorge A. García, Norbert Avril, et al.. (2024). Advances in prostate cancer treatment: Radionuclide therapy for prostate cancer. Advances in cancer research. 164. 311–358. 2 indexed citations
5.
Wang, Huafeng, Xudong Wei, Qian Jiang, et al.. (2024). Safety and efficacy of lisaftoclax, a novel BCL-2 inhibitor, in combination with azacitidine in patients with treatment-naïve or relapsed or refractory acute myeloid leukemia.. Journal of Clinical Oncology. 42(16_suppl). 6541–6541. 1 indexed citations
6.
Yang, Wei, Sujun Gao, Xiaojing Yan, et al.. (2024). Latest results of a phase 2 study of IMM01 combined with azacitidine (AZA) as the first-line treatment in adults with higher risk myelodysplastic syndromes (MDS).. Journal of Clinical Oncology. 42(16_suppl). 6510–6510.
7.
8.
Wang, Hongxiang, et al.. (2023). Procoagulant Properties of Mesenchymal Stem Cells and Extracellular Vesicles: A Novel Aspect of Thrombosis Pathogenesis. Stem Cells. 42(2). 98–106. 10 indexed citations
9.
Kang, Zhen, et al.. (2023). Management Strategy for Prostate Imaging Reporting and Data System Category 3 Lesions. Current Urology Reports. 24(12). 561–570. 4 indexed citations
10.
Cheng, Fang, Robert Peter Gale, Siyi Chen, et al.. (2023). SARS-CoV-2 Omicron BA.5.2-infection and COVID-19 in persons with chronic myeloid leukaemia. Journal of Cancer Research and Clinical Oncology. 149(13). 11025–11030. 1 indexed citations
11.
Zhang, Yuanyuan, Xin Gao, Heng Chen, et al.. (2022). Performance Analysis of a Waste-to-Energy System Integrated with the Steam–Water Cycle and Urea Hydrolysis Process of a Coal-Fired Power Unit. Applied Sciences. 12(2). 866–866. 2 indexed citations
12.
Li, Xiaohong, Basen Li, Muhammad Wajid Ullah, et al.. (2020). Water-stable and finasteride-loaded polyvinyl alcohol nanofibrous particles with sustained drug release for improved prostatic artery embolization — In vitro and in vivo evaluation. Materials Science and Engineering C. 115. 111107–111107. 13 indexed citations
13.
Wang, Liang, Min Chen, Qiubai Li, & Hebert Alberto Vargas. (2019). Artificial intelligence in prostate cancer imaging: state of the art and future directions. Zhonghua fangshexian yixue zazhi. 53(10). 804–807. 1 indexed citations
14.
Zhang, Liming, Qian Lei, Hongxiang Wang, et al.. (2018). Tumor-derived extracellular vesicles inhibit osteogenesis and exacerbate myeloma bone disease. Theranostics. 9(1). 196–209. 55 indexed citations
15.
Zhang, Hongmei, Qing Li, Xiaojian Zhu, et al.. (2016). miR-146b-5p within BCR-ABL1–Positive Microvesicles Promotes Leukemic Transformation of Hematopoietic Cells. Cancer Research. 76(10). 2901–2911. 81 indexed citations
16.
Ren, Wenxiang, et al.. (2015). Inhibitory effects of parthenolide on the activity of NF-κB in multiple myeloma via targeting TRAF6. Journal of Huazhong University of Science and Technology [Medical Sciences]. 35(3). 343–349. 14 indexed citations
17.
Zhao, Zhigang, Zhenling Wang, Qiubai Li, et al.. (2012). The Different Immunoregulatory Functions of Mesenchymal Stem Cells in Patients with Low-Risk or High-Risk Myelodysplastic Syndromes. PLoS ONE. 7(9). e45675–e45675. 42 indexed citations
18.
19.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xin Du Breakdown of academic impact, for papers by Bo Zheng Breakdown of academic impact, for papers by Myungshin Kim Breakdown of academic impact, for papers by José Vassallo Breakdown of academic impact, for papers by David M. Smadja Breakdown of academic impact, for papers by Aline Bözec Breakdown of academic impact, for papers by Kiarash Khosrotehrani Breakdown of academic impact, for papers by Léo H. Bühler Breakdown of academic impact, for papers by Andrea Onetti Muda Breakdown of academic impact, for papers by Bing Liu
Rankless by CCL
2026